Promising gene therapies pose million-dollar conundrum
Wednesday, June 15, 2016 - 03:30
in Health & Medicine
Economists, investors and medical insurers can’t figure out how to pay for cutting-edge drugs.Nature 534 305 doi: 10.1038/534305a